UnitedHealth Faces DOJ Probe on Medicare Billing Practices

UnitedHealth is cooperating with a Justice Department investigation into its Medicare billing practices. The company has not disclosed further details about the investigation.

Title: UnitedHealth Group Cooperates with DOJ Investigation into Medicare Billing Practices

UnitedHealth Group has confirmed it is cooperating with a Justice Department (DOJ) investigation into its Medicare billing practices. The company has not disclosed further details about the probe, but it has stated that it has full confidence in its practices and is committed to working cooperatively with the DOJ throughout the process.

The DOJ's investigation is part of a broader probe into potential Medicare fraud involving several major health insurance companies. UnitedHealth Group has been under scrutiny since the Wall Street Journal first reported the DOJ's interest in its Medicare billing practices in February [1]. The company has faced a series of challenges in recent years, including a historic cyberattack, the sudden departure of its CEO, and the murder of its CEO Brian Thompson, which has added to the company's troubles.

UnitedHealth Group's Medicare and retirement segment, which includes the Medicare Advantage business, is a significant revenue driver, generating $139 billion in sales last year. The company has proactively launched its own initiative to conduct third-party reviews of policies, practices, and associated processes and performance metrics for risk assessment coding, managed care practices, and pharmacy services [3].

The company's shares have been volatile in recent months. Following the initial report of the DOJ probe in February, UnitedHealth Group's stock slid 15%, adding to the company's list of problems that includes multiple government inquiries, a sudden change in top leadership, and a pulled outlook in the face of soaring medical costs [4]. In July, the company confirmed it was facing a criminal and civil investigation over its Medicare billing practices, leading to a nearly 4% drop in its shares in premarket trading [2].

UnitedHealth Group's cooperation with the DOJ investigation underscores its commitment to transparency and compliance. The company's proactive approach to addressing potential issues within its Medicare billing practices is a positive sign for investors, though the ongoing probe may continue to weigh on the company's stock performance.

References
[1] https://www.cnbc.com/2025/07/24/unitedhealthcare-doj-investigation-medicare-billing.html
[2] https://www.morningstar.com/news/dow-jones/202507247740/unitedhealth-group-reaches-out-to-justice-department-amid-reports-of-medicare-billing-probe
[3] https://finance.yahoo.com/news/unitedhealth-stock-drops-after-company-confirms-doj-investigation-into-medicare-billing-practices-133527905.html
[4] https://www.foxbusiness.com/politics/unitedhealth-confirms-sweeping-doj-probe-medicare-billing-vows-compliance